Number: RL33717
Title: Pharmaceutical Patent Litigation Settlements: Implications for Competition and Innovation
Authors: John R. Thomas, Resources, Science, and Industry Division 
Abstract: This report introduces and analyzes innovation policy issues concerning pharmaceutical patent litigation settlements. It begins with a review of pharmaceutical patent litigation procedures under the Hatch-Waxman Act. The report then introduces the concept of reverse payment settlements. Next, the report analyzes the status of reverse payment settlements under the antitrust laws. The report closes with a summary of congressional issues and alternatives.
Pages: 23
Date: November 4, 2008